Swiss trial begins of banker alleged to have ignored 1MDB warnings
A banker went on trial in Switzerland on Tuesday charged with failing to sound the alarm over millions of dollars linked to scandal-tainted Malaysian sovereign wealth fund 1MDB.
A banker went on trial in Switzerland on Tuesday charged with failing to sound the alarm over millions of dollars linked to scandal-tainted Malaysian sovereign wealth fund 1MDB.
U.S. passenger railroad Amtrak told Congress in a letter made public Tuesday it needs another $1.475 billion bailout or it will be forced to make sweeping service cuts and likely suspend some routes.
U.S. stocks jumped and the S&P 500 breached 3,000 points on Tuesday as optimism about a potential coronavirus vaccine and a revival in business activity helped investors overlook simmering Sino-U.S. tensions.
What is the difference between rich and wealthy? At first, you might assume there is no difference. After all, the two terms are often used as synonyms. Why assume there is a distinction?
But on closer inspection, the two terms begin to diverge. In fact, the two can be seen as entirely different concepts. Suddenly, being rich appears distinct from becoming wealthy.
In this article, I want to take a look at the difference between being rich and being wealthy. I think by the end of the article, you’ll not only understand the difference. But you’ll understand which one you want to …read more […]
Nela Richardson, Edward Jones Investment Strategist, joins Yahoo Finance’s Alexis Christoforous and Brian Sozzi to discuss overall markets and what she is keeping a close watch on. …read more […]
British supercar manufacturer McLaren Group, which includes the Formula One team, said on Tuesday it would cut 1,200 jobs under a proposed restructuring programme as it deals with the fallout from the COVID-19 pandemic.
Sales of new U.S. single-family homes unexpectedly rose in April, but the gains are likely temporary as the coronavirus crisis ravages the economy, unleashing record unemployment.
In the first-quarter, Target posted a beat on both its top and bottom line. The retail giant also saw a spike in digital comparable sales up 141%. Yahoo Finance’s Brian Sozzi and Alexis Christoforous speak to Brian Cornell, Target chairman & CEO about the current state of the business and the future outlook of the store, including the importance of safety. …read more […]
British retailer John Lewis Partnership said on Tuesday it will re-open its department stores on a “phased basis” after the government said “non-essential” retail could re-open from June 15.
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Anjalee Khemlani speak with Novavax R&D President Dr. Gregory Glenn about the company’s coronavirus vaccine candidate. …read more […]
Yahoo Finance’s Brian Sozzi and Alexis Christoforous break down the market action with Invesco Chief Global Market Strategist Kristina Hooper.
…read more […]
U.S. stocks surged at the open and S&P 500 breached a major technical barrier on Tuesday as business restarts and optimism about a potential coronavirus vaccine helped investors overlook Sino-U.S. tensions.
U.S. stocks rose above the 3,000 level for the first time since March 5 on Tuesday, continuing a rally that has pushed the benchmark index up nearly 35% from its March 23 closing low on hopes for a potential coronavirus vaccine and the reopening of businesses across the country.
Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.
Merck & Co. (MRK) on Tuesday became the latest drugmaker to join the race for the development of a COVID-19 treatment by announcing the purchase of Austrian vaccine maker Themis Bioscience and the collaboration with non-profit research group IAVI.Shares in Merck rose 4% to $79.40 in U.S. pre-market trading. The drugmaker said that the Themis acquisition builds upon an ongoing collaboration between the two companies to develop vaccine candidates using the measles virus vector platform, and is expected to accelerate the development of Themis’ COVID-19 vaccine candidate. The vaccine candidate is in pre-clinical development, and clinical studies are planned to …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.